In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

The in vitro activities of GAR-936, the 9-t-butylglycylamido derivative of minocycline, were compared with those of doxycycline, minocycline, and tetracycline against 527 gram-positive clinical isolates. GAR-936 inhibited all strains, including those resistant to other tetracyclines, at concentratio...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Boucher, Helen W., Wennersten, Christine B., Eliopoulos, George M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90048/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898710/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2225-2229.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!